The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Glaucoma-Global Market Insights and Sales Trends 2024
Synopsis
Glaucoma is an asymptomatic eye-related disorder that occurs due to the buildup of fluid pressure inside the eye. This leads to damage of the optic nerve in the eye, and is a hereditary disorder. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may result in loss of vision permanently. In addition, glaucoma is anticipated to be the leading cause of blindness among people in the age group of 60 years and above. The glaucoma surgeries comprise of non-invasive devices, invasive as well as minimally invasive devices to decrease the production of intraocular fluid, which is also known as aqueous humor.
The global Glaucoma market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Glaucoma in various end use industries. The expanding demands from the Eye Hospitals, Ophthalmology Clinics and Outpatient Surgical Centers,, are propelling Glaucoma market. Conventional Glaucoma Surgeries, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Minimally Invasive Glaucoma Surgeries segment is estimated at % CAGR for the next seven-year period.
The key factors that drive the market growth include increase in prevalence of glaucoma disease worldwide and growth in geriatric population. In addition, rise in demand for advanced ophthalmic devices supplement the market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glaucoma, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glaucoma market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glaucoma market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glaucoma sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glaucoma covered in this report include Novartis, Glaukos, New World Medical, Ellex Medical Lasers, Abbott Laboratories, Johnson & Johnson, Bausch Health（BHC）, Topcon and Lumenis, etc.
The global Glaucoma market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Glaukos
New World Medical
Ellex Medical Lasers
Abbott Laboratories
Johnson & Johnson
Bausch Health（BHC）
Topcon
Lumenis
Allergan
Nidek
HAAG-Streit Holding
Essilor International
Hoya
Ziemer Ophthalmic Systems
Carl Zeiss Meditec
Sonomed Escalon
HumanOptics
PhysIOL
Calhoun Vision Center
RISI
Global Glaucoma market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glaucoma market, Segment by Type:
Conventional Glaucoma Surgeries
Minimally Invasive Glaucoma Surgeries
Global Glaucoma market, by Application
Eye Hospitals
Ophthalmology Clinics
Outpatient Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glaucoma companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Glaucoma is an asymptomatic eye-related disorder that occurs due to the buildup of fluid pressure inside the eye. This leads to damage of the optic nerve in the eye, and is a hereditary disorder. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may result in loss of vision permanently. In addition, glaucoma is anticipated to be the leading cause of blindness among people in the age group of 60 years and above. The glaucoma surgeries comprise of non-invasive devices, invasive as well as minimally invasive devices to decrease the production of intraocular fluid, which is also known as aqueous humor.
The global Glaucoma market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Glaucoma in various end use industries. The expanding demands from the Eye Hospitals, Ophthalmology Clinics and Outpatient Surgical Centers,, are propelling Glaucoma market. Conventional Glaucoma Surgeries, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Minimally Invasive Glaucoma Surgeries segment is estimated at % CAGR for the next seven-year period.
The key factors that drive the market growth include increase in prevalence of glaucoma disease worldwide and growth in geriatric population. In addition, rise in demand for advanced ophthalmic devices supplement the market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glaucoma, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glaucoma market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glaucoma market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glaucoma sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glaucoma covered in this report include Novartis, Glaukos, New World Medical, Ellex Medical Lasers, Abbott Laboratories, Johnson & Johnson, Bausch Health（BHC）, Topcon and Lumenis, etc.
The global Glaucoma market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Glaukos
New World Medical
Ellex Medical Lasers
Abbott Laboratories
Johnson & Johnson
Bausch Health（BHC）
Topcon
Lumenis
Allergan
Nidek
HAAG-Streit Holding
Essilor International
Hoya
Ziemer Ophthalmic Systems
Carl Zeiss Meditec
Sonomed Escalon
HumanOptics
PhysIOL
Calhoun Vision Center
RISI
Global Glaucoma market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glaucoma market, Segment by Type:
Conventional Glaucoma Surgeries
Minimally Invasive Glaucoma Surgeries
Global Glaucoma market, by Application
Eye Hospitals
Ophthalmology Clinics
Outpatient Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glaucoma companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Glaucoma
1.1 Glaucoma Market Overview
1.1.1 Glaucoma Product Scope
1.1.2 Glaucoma Market Status and Outlook
1.2 Global Glaucoma Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Glaucoma Market Size by Region (2018-2029)
1.4 Global Glaucoma Historic Market Size by Region (2018-2023)
1.5 Global Glaucoma Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Glaucoma Market Size (2018-2029)
1.6.1 North America Glaucoma Market Size (2018-2029)
1.6.2 Europe Glaucoma Market Size (2018-2029)
1.6.3 Asia-Pacific Glaucoma Market Size (2018-2029)
1.6.4 Latin America Glaucoma Market Size (2018-2029)
1.6.5 Middle East & Africa Glaucoma Market Size (2018-2029)
2 Glaucoma Market by Type
2.1 Introduction
2.1.1 Conventional Glaucoma Surgeries
2.1.2 Minimally Invasive Glaucoma Surgeries
2.2 Global Glaucoma Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Glaucoma Historic Market Size by Type (2018-2023)
2.2.2 Global Glaucoma Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Glaucoma Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Glaucoma Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Glaucoma Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Glaucoma Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Glaucoma Revenue Breakdown by Type (2018-2029)
3 Glaucoma Market Overview by Application
3.1 Introduction
3.1.1 Eye Hospitals
3.1.2 Ophthalmology Clinics
3.1.3 Outpatient Surgical Centers
3.2 Global Glaucoma Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Glaucoma Historic Market Size by Application (2018-2023)
3.2.2 Global Glaucoma Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Glaucoma Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Glaucoma Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Glaucoma Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Glaucoma Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Glaucoma Revenue Breakdown by Application (2018-2029)
4 Glaucoma Competition Analysis by Players
4.1 Global Glaucoma Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glaucoma as of 2022)
4.3 Date of Key Players Enter into Glaucoma Market
4.4 Global Top Players Glaucoma Headquarters and Area Served
4.5 Key Players Glaucoma Product Solution and Service
4.6 Competitive Status
4.6.1 Glaucoma Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Glaucoma Products, Services and Solutions
5.1.4 Novartis Glaucoma Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Glaukos
5.2.1 Glaukos Profile
5.2.2 Glaukos Main Business
5.2.3 Glaukos Glaucoma Products, Services and Solutions
5.2.4 Glaukos Glaucoma Revenue (US$ Million) & (2018-2023)
5.2.5 Glaukos Recent Developments
5.3 New World Medical
5.3.1 New World Medical Profile
5.3.2 New World Medical Main Business
5.3.3 New World Medical Glaucoma Products, Services and Solutions
5.3.4 New World Medical Glaucoma Revenue (US$ Million) & (2018-2023)
5.3.5 Ellex Medical Lasers Recent Developments
5.4 Ellex Medical Lasers
5.4.1 Ellex Medical Lasers Profile
5.4.2 Ellex Medical Lasers Main Business
5.4.3 Ellex Medical Lasers Glaucoma Products, Services and Solutions
5.4.4 Ellex Medical Lasers Glaucoma Revenue (US$ Million) & (2018-2023)
5.4.5 Ellex Medical Lasers Recent Developments
5.5 Abbott Laboratories
5.5.1 Abbott Laboratories Profile
5.5.2 Abbott Laboratories Main Business
5.5.3 Abbott Laboratories Glaucoma Products, Services and Solutions
5.5.4 Abbott Laboratories Glaucoma Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Laboratories Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Glaucoma Products, Services and Solutions
5.6.4 Johnson & Johnson Glaucoma Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson & Johnson Recent Developments
5.7 Bausch Health（BHC）
5.7.1 Bausch Health（BHC） Profile
5.7.2 Bausch Health（BHC） Main Business
5.7.3 Bausch Health（BHC） Glaucoma Products, Services and Solutions
5.7.4 Bausch Health（BHC） Glaucoma Revenue (US$ Million) & (2018-2023)
5.7.5 Bausch Health（BHC） Recent Developments
5.8 Topcon
5.8.1 Topcon Profile
5.8.2 Topcon Main Business
5.8.3 Topcon Glaucoma Products, Services and Solutions
5.8.4 Topcon Glaucoma Revenue (US$ Million) & (2018-2023)
5.8.5 Topcon Recent Developments
5.9 Lumenis
5.9.1 Lumenis Profile
5.9.2 Lumenis Main Business
5.9.3 Lumenis Glaucoma Products, Services and Solutions
5.9.4 Lumenis Glaucoma Revenue (US$ Million) & (2018-2023)
5.9.5 Lumenis Recent Developments
5.10 Allergan
5.10.1 Allergan Profile
5.10.2 Allergan Main Business
5.10.3 Allergan Glaucoma Products, Services and Solutions
5.10.4 Allergan Glaucoma Revenue (US$ Million) & (2018-2023)
5.10.5 Allergan Recent Developments
5.11 Nidek
5.11.1 Nidek Profile
5.11.2 Nidek Main Business
5.11.3 Nidek Glaucoma Products, Services and Solutions
5.11.4 Nidek Glaucoma Revenue (US$ Million) & (2018-2023)
5.11.5 Nidek Recent Developments
5.12 HAAG-Streit Holding
5.12.1 HAAG-Streit Holding Profile
5.12.2 HAAG-Streit Holding Main Business
5.12.3 HAAG-Streit Holding Glaucoma Products, Services and Solutions
5.12.4 HAAG-Streit Holding Glaucoma Revenue (US$ Million) & (2018-2023)
5.12.5 HAAG-Streit Holding Recent Developments
5.13 Essilor International
5.13.1 Essilor International Profile
5.13.2 Essilor International Main Business
5.13.3 Essilor International Glaucoma Products, Services and Solutions
5.13.4 Essilor International Glaucoma Revenue (US$ Million) & (2018-2023)
5.13.5 Essilor International Recent Developments
5.14 Hoya
5.14.1 Hoya Profile
5.14.2 Hoya Main Business
5.14.3 Hoya Glaucoma Products, Services and Solutions
5.14.4 Hoya Glaucoma Revenue (US$ Million) & (2018-2023)
5.14.5 Hoya Recent Developments
5.15 Ziemer Ophthalmic Systems
5.15.1 Ziemer Ophthalmic Systems Profile
5.15.2 Ziemer Ophthalmic Systems Main Business
5.15.3 Ziemer Ophthalmic Systems Glaucoma Products, Services and Solutions
5.15.4 Ziemer Ophthalmic Systems Glaucoma Revenue (US$ Million) & (2018-2023)
5.15.5 Ziemer Ophthalmic Systems Recent Developments
5.16 Carl Zeiss Meditec
5.16.1 Carl Zeiss Meditec Profile
5.16.2 Carl Zeiss Meditec Main Business
5.16.3 Carl Zeiss Meditec Glaucoma Products, Services and Solutions
5.16.4 Carl Zeiss Meditec Glaucoma Revenue (US$ Million) & (2018-2023)
5.16.5 Carl Zeiss Meditec Recent Developments
5.17 Sonomed Escalon
5.17.1 Sonomed Escalon Profile
5.17.2 Sonomed Escalon Main Business
5.17.3 Sonomed Escalon Glaucoma Products, Services and Solutions
5.17.4 Sonomed Escalon Glaucoma Revenue (US$ Million) & (2018-2023)
5.17.5 Sonomed Escalon Recent Developments
5.18 HumanOptics
5.18.1 HumanOptics Profile
5.18.2 HumanOptics Main Business
5.18.3 HumanOptics Glaucoma Products, Services and Solutions
5.18.4 HumanOptics Glaucoma Revenue (US$ Million) & (2018-2023)
5.18.5 HumanOptics Recent Developments
5.19 PhysIOL
5.19.1 PhysIOL Profile
5.19.2 PhysIOL Main Business
5.19.3 PhysIOL Glaucoma Products, Services and Solutions
5.19.4 PhysIOL Glaucoma Revenue (US$ Million) & (2018-2023)
5.19.5 PhysIOL Recent Developments
5.20 Calhoun Vision Center
5.20.1 Calhoun Vision Center Profile
5.20.2 Calhoun Vision Center Main Business
5.20.3 Calhoun Vision Center Glaucoma Products, Services and Solutions
5.20.4 Calhoun Vision Center Glaucoma Revenue (US$ Million) & (2018-2023)
5.20.5 Calhoun Vision Center Recent Developments
5.21 RISI
5.21.1 RISI Profile
5.21.2 RISI Main Business
5.21.3 RISI Glaucoma Products, Services and Solutions
5.21.4 RISI Glaucoma Revenue (US$ Million) & (2018-2023)
5.21.5 RISI Recent Developments
6 North America
6.1 North America Glaucoma Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Glaucoma Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Glaucoma Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Glaucoma Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Glaucoma Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Glaucoma Market Dynamics
11.1 Glaucoma Industry Trends
11.2 Glaucoma Market Drivers
11.3 Glaucoma Market Challenges
11.4 Glaucoma Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
